1216-OR: Added Sugars from Desserts, Gut Bifidobacterium, and Steatotic Liver Disease in Hispanic/Latino Adults
Diabetes · 06.06.2026 · 75 (Supplement_1)
DOI: 10.2337/db26-1216-or ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, erschienen am 06.06.2026. Verfasst von YANBO ZHANG und 11 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction and Objective: Human evidence is lacking on whether added sugar intake affects liver function via gut microbes. We examined associations of added sugar intake from desserts, a major added sugar source, with liver fibrosis (FIB-4), MRI liver fat (PDFF) and inflammation (native T1), gut microbiota, and metabolites in Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
Methods
Among 12,345 adults free of advanced liver disease in 2008-11 (V1), usual added sugar intake from desserts (pastries, candies, and sweet snacks) was estimated with two 24-hour recalls and food propensity questionnaires by NCI methods. We examined: 1) associations of added sugar intake from desserts with longitudinal FIB-4 (22,820 observations via 2024), gut microbial species (shotgun metagenomics; n=2770, V2: 2014-17), and blood metabolites (n=5424, V1); 2) associations of gut microbes with liver outcomes (FIB-4, PDFF, native T1; n=726, V3: 2020-24) and blood metabolites (n=722, V2). Demographic, lifestyle, dietary, metabolic, and gut covariates were adjusted.
Results
Higher added sugar intake from desserts was related to higher FIB-4 (per 5% daily energy, β=0.10, 95% CI 0.03-0.17). It was also related to 23 of 198 microbes (MaAsLin; FDR<0.25), including higher Bifidobacterium bifidum, B. breve, B. dentium, B. angulatum, and B. longum, commonly implicated in glucose/fructose metabolism and host lipogenesis. These Bifidobacterium species were also positively related to PDFF and/or native T1. Metabolomics analyses identified 26 of 653 metabolites showing significant and directionally consistent associations with added sugar intake from desserts, at least one Bifidobacterium species, and PDFF and/or native T1, including higher phosphatidylinositols (e.g., PI(16:0/18:1)) and lower microbial phenylalanine metabolites (e.g., 4-ethylphenylsulfate).
Conclusion
In Hispanic/Latino adults, added sugar intake from desserts was related to liver fibrosis and Bifidobacterium species and related metabolites linked to liver fat and inflammation. Disclosure Y. Zhang: None. T. Wang: None. Q. Qi: None. D. Sotres-Alvarez: None. D. Kanmaniraja: None. M. Naveed: None. S. Shitole: None. C. Cordero: None. J.A. Lima: None. J.C. Price: Research Support; Current; AbbVie Inc., Gilead Sciences, Inc., VIR, Aligos. Research Support; Ended; Cepheid. J.R. Kizer: Stock/Shareholder; Ended; Abbott, AbbVie Inc., Bristol-Myers Squibb Company, Johnson & Johnson, Lilly, Medtronic, Merck & Co., Inc., Pfizer Inc. R. Kaplan: None.
Zitieren
APA
ZHANG, Y., WANG, T., QI, Q., SOTRES-ALVAREZ, D., KANMANIRAJA, D., NAVEED, M., SHITOLE, S., CORDERO, C., LIMA, J. A., PRICE, J. C., KIZER, J. R., & KAPLAN, R. (2026). 1216-OR: Added Sugars from Desserts, Gut Bifidobacterium, and Steatotic Liver Disease in Hispanic/Latino Adults. Diabetes, 75(Supplement_1). https://doi.org/10.2337/db26-1216-or
Vancouver
ZHANG Y, WANG T, QI Q, SOTRES-ALVAREZ D, KANMANIRAJA D, NAVEED M, et al. 1216-OR: Added Sugars from Desserts, Gut Bifidobacterium, and Steatotic Liver Disease in Hispanic/Latino Adults. Diabetes. 2026;75(Supplement_1). doi:10.2337/db26-1216-or
BibTeX
@article{ZHANG2026,
author = {ZHANG, YANBO and WANG, TAO and QI, QIBIN and SOTRES-ALVAREZ, DANIELA and KANMANIRAJA, DEVARAJU and NAVEED, MAHIM and SHITOLE, SANYOG and CORDERO, CHRISTINA and LIMA, JOAO A. and PRICE, JENNIFER C. and KIZER, JORGE R. and KAPLAN, ROBERT},
title = {1216-OR: Added Sugars from Desserts, Gut Bifidobacterium, and Steatotic Liver Disease in Hispanic/Latino Adults},
journal = {Diabetes},
year = {2026},
volume = {75},
number = {Supplement_1},
doi = {10.2337/db26-1216-or}
}
EUVIMED